Assyro AI

Orange Book product · Generic (ANDA)

SEVOFLURANE

SEVOFLURANE

Generic (ANDA)ANDA 214382TE ANRX SHANDONG

At a glance

Aug 18, 2023

Approved

Generic (ANDA)

Application

AN

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Aug 18, 2023

    2 yr 11 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

SEVOFLURANE

Strength

100%

Dosage form

LIQUID

Route

INHALATION

TE code

AN

Application

ANDA 214382

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of SEVOFLURANE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.